Severe diffuse axonal injury (DAI) results from rapid acceleration/deceleration forces that shear white matter tracts, causing immediate coma (GCS ≤8) and widespread axonal disruption across the hemispheric white matter, corpus callosum, and brainstem. [1-2] It is graded by depth of injury: Grade 1 (lobar white matter), Grade 2 (corpus callosum), and Grade 3 (brainstem — the hallmark of severe DAI). [3-4] DAI is rarely associated with elevated ICP but carries a high risk of poor functional outcome, particularly with brainstem involvement. [1-2]
1. History
- Mechanism: High-energy acceleration/deceleration — motor vehicle collisions (most common), motorcycle crashes, high-speed falls, blast injuries, assaults [2][5]
- Immediate and sustained loss of consciousness from the moment of impact — distinguishes DAI from mass lesions where lucid intervals may occur [6-7]
- Duration of coma: Coma >24 hours with brainstem signs defines the most severe category [8]
- Witnesses: Speed of impact, ejection from vehicle, helmet use, airbag deployment, height of fall
- Pre-injury anticoagulant/antiplatelet use, alcohol/drug intoxication
2. Alarm Features
- GCS ≤8 at presentation, especially GCS motor score <6 [9]
- Bilateral fixed/dilated pupils or asymmetric pupillary response (brainstem involvement) [10]
- Posturing (decerebrate > decorticate) [11]
- Rapid neurological deterioration suggesting concomitant expanding hematoma
- Signs of herniation: Cushing triad (hypertension, bradycardia, irregular respirations)
- Paroxysmal sympathetic hyperactivity (PSH): episodic tachycardia, hypertension, diaphoresis, posturing, fever [12]
3. Medications
- Seizure prophylaxis: Levetiracetam or phenytoin for 7 days post-injury (early post-traumatic seizure prevention); no evidence for prolonged prophylaxis [9][13]
- Sedation/analgesia: Propofol, midazolam, fentanyl — titrated to ICP control [9]
- Osmotherapy: Mannitol 0.25–1.0 g/kg bolus or hypertonic saline (3–23.4%) for ICP crises; serum Na limit 155 mEq/L, osmolality limit 320 mOsm/L [9][13]
- Avoid: Corticosteroids — increased mortality per CRASH trial; routine hypothermia not recommended due to adverse effects [14-15]
- VTE prophylaxis: Pharmacologic prophylaxis should be initiated when safe (typically 24–72 hours post-injury, guided by repeat imaging stability) [12]
- No proven neuroprotective agents exist for DAI [6][15]
4. Diet
- Early enteral nutrition (within 24–72 hours) is recommended per BTF guidelines to reduce mortality and improve outcomes [12][16]
- Caloric targets: 140% of resting metabolic expenditure in non-paralyzed patients; 100% in paralyzed patients
- Avoid hyperglycemia (target glucose 100–180 mg/dL); hypoglycemia is particularly harmful to the injured brain [2]
5. Review of Systems
- Neurologic: Level of consciousness, pupillary response, motor response, cranial nerve function, seizure activity
- Respiratory: Aspiration risk, neurogenic pulmonary edema, ventilator-associated pneumonia
- Cardiovascular: Autonomic dysregulation, PSH, neurogenic cardiac injury
- GI: Stress ulcer risk, ileus
- Hematologic: Coagulopathy (trauma-induced or DIC), DVT/PE risk
- Endocrine: Pituitary dysfunction (diabetes insipidus, SIADH, adrenal insufficiency) — common after severe TBI
6. Collateral History and Family History
- Pre-injury functional status, cognitive baseline, psychiatric history
- Advance directives, healthcare proxy — critical for goals-of-care discussions
- Substance use history (alcohol intoxication confounds GCS assessment)
- Family history of bleeding disorders or coagulopathy
- Social context: mechanism details from EMS, bystanders, law enforcement; concern for non-accidental trauma in pediatric cases
7. Risk Factors
- High-speed motor vehicle collisions (most common mechanism) [2][5]
- Motorcycle/bicycle crashes without helmet
- Falls from significant height
- Blast exposure (military/combat) [5]
- Contact sports with high-velocity impacts
- Young males (peak incidence 15–35 years) [11]
- Anticoagulant use (increases hemorrhagic component)
- Alcohol intoxication at time of injury
8. Differential Diagnosis
- Epidural/subdural hematoma: Lucid interval possible; mass effect on CT; surgical emergency
- Cerebral contusions: Focal deficits; hemorrhagic lesions on CT, often frontal/temporal
- Diffuse cerebral edema/swelling: Loss of gray-white differentiation on CT; elevated ICP
- Hypoxic-ischemic brain injury: Post-cardiac arrest or prolonged hypotension; diffuse cortical/basal ganglia restriction on MRI [17]
- Cerebral venous sinus thrombosis: Consider if mechanism atypical
- Fat embolism syndrome: Delayed onset (24–72 hours post long-bone fracture); petechial rash, hypoxia
- Toxic/metabolic encephalopathy: Drug intoxication, hypoglycemia — must be excluded before attributing coma to DAI
- Non-convulsive status epilepticus: Requires EEG to diagnose; can mimic persistent coma
9. Past Medical History
- Prior TBI or concussions (cumulative axonal vulnerability) [18]
- Pre-existing neurological conditions (dementia, epilepsy)
- Anticoagulant/antiplatelet therapy
- Chronic alcohol use (brain atrophy increases shearing vulnerability)
- Coagulopathies
10. Physical Exam
- GCS assessment[9]
- Pupils: Bilateral fixed/dilated suggests brainstem DAI (Grade 3); unilateral dilation raises concern for concurrent herniation [10]
- Motor exam: Posturing patterns — decerebrate (brainstem) vs. decorticate (subcortical); asymmetry suggests focal lesion
- Brainstem reflexes: Corneal, oculocephalic (doll's eyes), oculovestibular (calorics), gag/cough
- Vital signs: Hypertension/bradycardia (Cushing response); autonomic instability (PSH)
- Full trauma survey: C-spine, chest, abdomen, pelvis, extremities — polytrauma is common [12]
11. Lab Studies
- Stat labs: CBC, CMP, coagulation panel (PT/INR, PTT, fibrinogen), type and screen, blood alcohol level, urine drug screen, lactate, ABG
- Biomarkers: GFAP (peaks ~20 hours) and UCH-L1 (peaks ~8 hours) — FDA-cleared for ruling out intracranial hemorrhage; elevated levels correlate with injury severity and mortality [9][19-20]
- Serum sodium: Monitor closely for SIADH (hyponatremia) or diabetes insipidus (hypernatremia)
- Coagulopathy correction: Fibrinogen <200 mg/dL, INR >1.5, platelet count <100K all require urgent correction [14]
- Neurofilament light chain (NfL): Emerging prognostic biomarker; strongest association with 6-month poor outcome [19]
12. Imaging
- Non-contrast CT head (first-line, immediate): Often normal or near-normal in pure DAI — this is a key clinical pearl. May show: [1][21]
- Punctate hemorrhages at gray-white junction, corpus callosum, or brainstem [22]
- Midline traumatic subarachnoid hemorrhage (surrogate marker for severe DAI; sensitivity 60.8%, specificity 81.7%) [23]
- Intraventricular hemorrhage [23]
- Petechial hemorrhages disproportionate to the severity of coma
- MRI brain (gold standard for DAI detection, obtained when patient is stable): [9][24]
- SWI/GRE sequences: Most sensitive for hemorrhagic microbleeds (hemosiderin deposits)
- FLAIR: Non-hemorrhagic white matter lesions
- DWI/ADC: Restricted diffusion in acute axonal injury
- DTI (diffusion tensor imaging): Research tool; quantifies white matter tract integrity [25-26]
- Protocol: T1, T2, FLAIR, DWI/ADC, SWI (or T2-GRE) [9]
- CT angiography: Consider for associated vascular injury (dissection, traumatic aneurysm) [1]
- CT C-spine: Mandatory in all severe TBI
13. Special Tests
- DAI Grading (Adams Classification)[3-4]
- Rotterdam CT Score: Prognostic scoring for TBI based on CT findings [11]
- IMPACT Prognostic Calculator: Validated model incorporating age, GCS motor score, pupillary reactivity, CT classification, and biomarkers [28]
- Continuous EEG monitoring: Detect subclinical seizures and spreading depolarizations [9][13]
- Pupillometry: Quantitative assessment of pupillary reactivity; aids in detecting intracranial hypertension non-invasively [14]
- Optic nerve sheath diameter (ONSD): Ultrasound-based; >5 mm suggests elevated ICP [14]
14. ECG
- Obtain baseline ECG in all severe TBI patients
- Neurogenic cardiac injury: ST changes, T-wave inversions, QT prolongation, arrhythmias
- Troponin elevation may occur from catecholamine surge (neurogenic stunned myocardium)
- Rule out cardiac contusion in polytrauma
15. Assessment
- Severe DAI is a clinical-radiographic diagnosis: coma from the moment of impact + characteristic MRI findings in white matter tracts [6-7]
- CT may be misleadingly normal — a comatose patient with a normal CT after high-energy mechanism should raise strong suspicion for DAI [1][21]
- DAI is rarely associated with elevated ICP (unlike mass lesions), but ICP monitoring is still indicated for GCS ≤8 [1-2]
- Prognosis is primarily determined by depth of injury (brainstem involvement is the strongest negative prognostic factor) rather than total lesion burden [3-4]
- Importantly, 51% of DAI patients achieve favorable long-term functional outcome (GOSE 6–8), and even Grade 3 patients can recover — prognostic humility is essential [10][29]
- Functional improvement is most pronounced in the first 3 months post-injury [8]
16. Treatment Plan
Initial Stabilization (ED)
- Airway: Rapid sequence intubation for GCS ≤8; avoid hypoxia (SpO₂ >90%) and hypotension (SBP >100 mmHg) [9][14]
- C-spine immobilization until cleared
- Correct coagulopathy emergently (FFP, PCC, platelets, cryoprecipitate as indicated) [14]
- Avoid hyperthermia: Target normothermia (36–37°C)
ICU Management (Tiered ICP Approach per SIBICC/BTF) [9][13][30]
- Tier 0 (Basic care): HOB 30°, head midline, normothermia, euvolemia, PaCO₂ 35–38 mmHg, seizure prophylaxis × 7 days
- Tier 1: Increase sedation/analgesia, osmotherapy (mannitol or hypertonic saline), CSF drainage via EVD, consider EEG monitoring; CPP target 60–70 mmHg
- Tier 2: Mild hyperventilation (PaCO₂ 32–35 mmHg), neuromuscular blockade (trial dose first), MAP augmentation
- Tier 3: Barbiturate coma (pentobarbital, titrated to ICP control/burst suppression), decompressive craniectomy, mild hypothermia (35–36°C) [9]
No surgical target in pure DAI (unlike hematomas/contusions) — management is entirely medical/supportive [1-2]
17. Disposition
- All severe DAI patients require ICU admission with ICP monitoring (EVD or parenchymal probe) [1][12]
- Neurosurgical consultation mandatory
- Transfer to Level I trauma center if not already at one [9]
- Prolonged ICU stay expected (median ~6 days for Grade 1; longer for Grades 2–3) [11]
- Transition to acute inpatient rehabilitation when medically stable and able to participate (even minimally)
- Avoid premature withdrawal of life-sustaining treatment — recovery can occur weeks to months after injury, particularly in younger patients [8][10][29]
18. Follow Up / Return Precautions
- Inpatient rehabilitation is the standard post-acute pathway for survivors of severe DAI
- Serial neurological assessments: time to follow commands is a key recovery milestone (Grade 1: ~9 days; Grade 3: ~19 days) [11]
- MRI at subacute phase (when stable) for definitive DAI grading and prognostication [9][24]
- Monitor for late complications: post-traumatic epilepsy (risk persists beyond 7-day prophylaxis window), hydrocephalus, neuroendocrine dysfunction, chronic traumatic encephalopathy [12][18]
- Long-term neuropsychological follow-up for cognitive, behavioral, and emotional sequelae
- Family counseling: recovery trajectory is prolonged (most improvement in first 3–6 months, but gains can continue for 1–2 years) [8][10]
- Return precautions for discharged rehabilitation patients: new seizures, worsening headache, progressive cognitive decline, new focal deficits, behavioral changes
Images
References
1. Severe Traumatic Brain Injury: Targeted Management in the Intensive Care Unit. — Stocchetti N, Carbonara M, Citerio G, et al. The Lancet. Neurology. 2017.
2. Moderate and Severe Traumatic Brain Injury in Adults. — Maas AI, Stocchetti N, Bullock R. The Lancet. Neurology. 2008.
3. Prevalence and Impact of Diffuse Axonal Injury in Patients With Moderate and Severe Head Injury: A Cohort Study of Early Magnetic Resonance Imaging Findings and 1-Year Outcome. — Skandsen T, Kvistad KA, Solheim O, et al. Journal of Neurosurgery. 2010.
4. MRI and Clinical Variables for Prediction of Outcomes After Pediatric Severe Traumatic Brain Injury. — Ferrazzano PA, Rebsamen S, Field AS, et al. JAMA Network Open. 2024.
5. Management and Rehabilitation of Post-Acute Mild Traumatic Brain Injury (mTBI) (2021). — Maj Thomas J. Bayuk DO, Amy O. Bowles MD, Lt Col Andrew W. Bursaw DO, et al Department of Veterans Affairs. 2021.
6. Current Opportunities for Clinical Monitoring of Axonal Pathology in Traumatic Brain Injury. — Tsitsopoulos PP, Abu Hamdeh S, Marklund N. Frontiers in Neurology. 2017.
7. Current Concepts: Diffuse Axonal Injury-Associated Traumatic Brain Injury. — Meythaler JM, Peduzzi JD, Eleftheriou E, Novack TA. Archives of Physical Medicine and Rehabilitation. 2001.
8. Recovery of Patients With Pure Diffuse Axonal Injury Who Remained in a Coma for 6 Hours or More. — Almeida Vieira RC, Paiva WS, de Oliveira DV, et al. World Neurosurgery. 2018.
9. Best Practices In The Management Of Traumatic Brain Injury. — Geoffrey T. Manley MD PhD, Gregory W. Albert MD MPH FAANS FACS FAAP, Gretchen M. Brophy PharmD BCPS FCCP FCCM FNCS MCCM, et al American College of Surgeons (2024). 2024.
10. Patients With Diffuse Axonal Injury Can Recover to a Favorable Long-Term Functional and Quality of Life Outcome. — van Eijck M, van der Naalt J, de Jongh M, et al. Journal of Neurotrauma. 2018.
11. Diffuse Axonal Injury Pattern Predicts Timing of in-Hospital Neurologic Recovery: A Retrospective Case Series. — El-Abtah ME, Kashkoush A, Petitt JC, et al. World Neurosurgery. 2023.
12. Management and Challenges of Severe Traumatic Brain Injury. — Rakhit S, Nordness MF, Lombardo SR, et al. Seminars in Respiratory and Critical Care Medicine. 2021.
13. A Management Algorithm for Patients With Intracranial Pressure Monitoring: The Seattle International Severe Traumatic Brain Injury Consensus Conference (SIBICC). — Hawryluk GWJ, Aguilera S, Buki A, et al. Intensive Care Medicine. 2019.
14. The Management of Severe Traumatic Brain Injury in the Initial Postinjury Hours - Current Evidence and Controversies. — Hossain I, Rostami E, Marklund N. Current Opinion in Critical Care. 2023.
15. Early Management of Severe Traumatic Brain Injury. — Rosenfeld JV, Maas AI, Bragge P, et al. Lancet. 2012.
16. Acute Management of Traumatic Brain Injury. — Vella MA, Crandall ML, Patel MB. The Surgical Clinics of North America. 2017.
17. Coma Prognostication After Acute Brain Injury: A Review. — Fischer D, Edlow BL. JAMA Neurology. 2024.
18. Axonal Pathology in Traumatic Brain Injury. — Johnson VE, Stewart W, Smith DH. Experimental Neurology. 2013.
19. Prognostic Value of Blood-Based Protein Biomarkers in Traumatic Brain Injury: A Living Systematic Review and Meta-Analysis. — Mondello S, Amrein K, Czeiter E, et al. Journal of Neurotrauma. 2025.
20. Time Course and Diagnostic Accuracy of Glial and Neuronal Blood Biomarkers GFAP and UCH-L1 in a Large Cohort of Trauma Patients With and Without Mild Traumatic Brain Injury. — Papa L, Brophy GM, Welch RD, et al. JAMA Neurology. 2016.
21. Imaging the Brain. — Gilman S. The New England Journal of Medicine. 1998.
22. Imaging Findings in Diffuse Axonal Injury After Closed Head Trauma. — Parizel PM, Ozsarlak, Van Goethem JW, et al. European Radiology. 1998.
23. Traumatic Midline Subarachnoid Hemorrhage on Initial Computed Tomography as a Marker of Severe Diffuse Axonal Injury. — Mata-Mbemba D, Mugikura S, Nakagawa A, et al. Journal of Neurosurgery. 2018.
24. ACR Appropriateness Criteria® Head Trauma: 2021 Update. — Expert Panel on Neurological Imaging, Shih RY, Burns J, et al. Journal of the American College of Radiology : JACR. 2021.
25. Detecting Axonal Injury in Individual Patients After Traumatic Brain Injury. — Jolly AE, Bălăeţ M, Azor A, et al. Brain : A Journal of Neurology. 2021.
26. Diffuse Axonal Injury Has a Characteristic Multidimensional MRI Signature in the Human Brain. — Benjamini D, Iacono D, Komlosh ME, et al. Brain : A Journal of Neurology. 2021.
27. Diffuse Axonal Injury After Traumatic Brain Injury Is a Prognostic Factor for Functional Outcome: A Systematic Review and Meta-Analysis. — van Eijck MM, Schoonman GG, van der Naalt J, de Vries J, Roks G. Brain Injury. 2018.
28. Prognostic Value of Day-of-Injury Plasma GFAP and UCH-L1 Concentrations for Predicting Functional Recovery After Traumatic Brain Injury in Patients From the US TRACK-TBI Cohort: An Observational Cohort Study. — Korley FK, Jain S, Sun X, et al. The Lancet. Neurology. 2022.
29. "Don't Lose Hope Early": Hemorrhagic Diffuse Axonal Injury on Head Computed Tomography Is Not Associated With Poor Outcome in Moderate to Severe Traumatic Brain Injury Patients. — Henninger N, Compton RA, Khan MW, et al. The Journal of Trauma and Acute Care Surgery. 2018.
30. Intracranial Pressure Monitoring in Adult Patients With Traumatic Brain Injury: Challenges and Innovations. — Zoerle T, Beqiri E, Åkerlund CAI, et al. The Lancet. Neurology. 2024.